1-6 of 6
Kimberly R. Reynolds, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MS4A3 Improves Imatinib Response and Survival in BCR-ABL1 Primary TKI Resistance and in Blastic Transformation of Chronic Myeloid Leukemia

Anna M. Eiring, PhD, Jamshid S. Khorashad, MD PhD, Anupriya Agarwal, PhD, Clinton C. Mason, PhD, Fan Yu, MD, Hannah M. Redwine, Amber D. Bowler, Kevin C. Gantz, Kimberly R. Reynolds, MS, Phillip M. Clair, MS, David J. Anderson, MBA, Srinivas K Tantravahi, Shannon K. McWeeney, PhD, Brian J. Druker, MD, Derek L. Stirewalt, MD, Vivian G. Oehler, MD, Thomas O'Hare, PhD, Michael W. Deininger
Journal: Blood
Blood (2015) 126 (23): 14.
https://doi.org/10.1182/blood.V126.23.14.14
Published: 2015
Journal Articles

Direct Contact With Bone Marrow Stromal Cells Protects CML Progenitors From Imatinib Through Cytoplasmic Stabilization Of β-Catenin

Anna M. Eiring, PhD, David J. Anderson, MBA, Tian Y. Zhang, MD, PhD, Ira L. Kraft, BS, Kimberly R. Reynolds, MS, Anthony D. Pomicter, MS, Clinton C. Mason, PhD, Thomas O'Hare, Michael W. Deininger, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3982.
https://doi.org/10.1182/blood.V122.21.3982.3982
Published: 2013
Journal Articles

An Unbiased shRNA Library Screen Identifies Nucleocytoplasmic Transport As a Potential Target For Treatment Of Chronic Myeloid Leukemia

Jamshid Sorouri Khorashad, MD, PhD, FRCPath, Clinton C. Mason, PhD, Ira L. Kraft, BS, Kimberly R. Reynolds, MS, Anthony D. Pomicter, MS, Anna M. Eiring, PhD, Matthew S. Zabriskie, Anthony J Iovino, William Heaton, Srinivas K. Tantravahi, MBBS, MRCP, Michael Kauffman, MD, PhD, Sharon Schacham, PhD, MBA, Alex Chenchik, PhD, Kyle Bonneau, PhD, Thomas O'Hare, Michael W. Deininger, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2707.
https://doi.org/10.1182/blood.V122.21.2707.2707
Published: 2013
Journal Articles

BP5-087, a Novel STAT3 Inhibitor, Combines With BCR-ABL1 Inhibition To Overcome Kinase-Independent Resistance In Chronic Myeloid Leukemia

Anna M. Eiring, PhD, Ira L. Kraft, BS, Brent D.G. Page, PhD, Tian Y. Zhang, MD, PhD, Jamshid S. Khorashad, MD, PhD, FRCPath, Nadeem A. Vellore, PhD, Kimberly R. Reynolds, MS, Anthony D. Pomicter, MS, Anna V. Senina, MS, Matthew S. Zabriskie, BS, Shazia Ahmad, Clinton C. Mason, PhD, Richard Moriggl, PhD, Riccardo Baron, PhD, Thomas O'Hare, Patrick T. Gunning, PhD, Michael W. Deininger
Journal: Blood
Blood (2013) 122 (21): 854.
https://doi.org/10.1182/blood.V122.21.854.854
Published: 2013
Journal Articles

Next-Generation STAT3 Inhibitors As Targeted Therapeutics in Chronic Myeloid Leukemia.

Ira L Kraft, BS, Anna M. Eiring, PhD, Brent DG Page, BS, Clinton C Mason, PhD, Zhimin Gu, PhD, Jamshid S Khorashad, MD, PhD, David J Anderson, BA, Anthony D Pomicter, MS, Kimberly R Reynolds, MS, Johanna Estrada, Matthew S Zabriskie, BS, Patrick T Gunning, PhD, Thomas O'Hare, PhD, Michael W Deininger, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2445.
https://doi.org/10.1182/blood.V120.21.2445.2445
Published: 2012
Journal Articles

STAT3 Inhibition Synergizes with BCR-ABL1 Inhibition to Overcome Kinase-Independent TKI Resistance in Chronic Myeloid Leukemia (CML)

Anna M. Eiring, PhD, Ira L Kraft, BS, Brent DG Page, BS, David J Anderson, BA, Zhimin Gu, PhD, Jamshid S Khorashad, MD, PhD, Anthony D Pomicter, MS, Kimberly R Reynolds, MS, Matthew S Zabriskie, BS, Richard Moriggl, PhD, Patrick T Gunning, PhD, Thomas O'Hare, PhD, Michael W Deininger, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 31.
https://doi.org/10.1182/blood.V120.21.31.31
Published: 2012